Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

0QNV

Addex Therapeutics (0QNV)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0QNV
DateTimeSourceHeadlineSymbolCompany
04/29/202412:00AMUK RegulatoryAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyLSE:0QNVAddex Therapeutics Ltd
04/19/202412:00AMUK RegulatoryAddex to Present at the Swiss Biotech Day 2024LSE:0QNVAddex Therapeutics Ltd
04/18/202412:00AMUK RegulatoryAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
04/11/202412:00AMUK RegulatoryAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024LSE:0QNVAddex Therapeutics Ltd
04/03/202412:00AMUK RegulatoryAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersLSE:0QNVAddex Therapeutics Ltd
03/14/20241:00AMUK RegulatoryAddex to Present at the Bio-Europe Spring 2024 ConferenceLSE:0QNVAddex Therapeutics Ltd
01/31/202412:00AMUK RegulatoryAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.LSE:0QNVAddex Therapeutics Ltd
 Showing the most relevant articles for your search:LSE:0QNV